David O’Brien

994 total citations
32 papers, 560 citations indexed

About

David O’Brien is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, David O’Brien has authored 32 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 13 papers in Pathology and Forensic Medicine and 10 papers in Molecular Biology. Recurrent topics in David O’Brien's work include Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). David O’Brien is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). David O’Brien collaborates with scholars based in Ireland, United States and United Kingdom. David O’Brien's co-authors include Pairot Tayapongsak, John E. Hearst, Elisabeth Vandenberghe, Paul Browne, D Ma, David N. Cook, Bhupinder S. Hundle, Stephen E. Langabeer, Peter Beyer and Eibhlin Conneally and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and FEBS Letters.

In The Last Decade

David O’Brien

32 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David O’Brien Ireland 13 161 154 145 126 110 32 560
Katia Chieregato Italy 12 317 2.0× 112 0.7× 146 1.0× 174 1.4× 33 0.3× 26 542
Laurent Bégot France 6 405 2.5× 88 0.6× 266 1.8× 269 2.1× 15 0.1× 10 621
Valentina Devescovi Italy 13 143 0.9× 295 1.9× 136 0.9× 162 1.3× 49 0.4× 19 756
Francisco Carbonell‐Uberos Spain 14 447 2.8× 188 1.2× 115 0.8× 243 1.9× 11 0.1× 26 737
Gang Ding China 9 518 3.2× 218 1.4× 288 2.0× 224 1.8× 29 0.3× 14 860
Jianmao Zheng China 14 123 0.8× 437 2.8× 79 0.5× 70 0.6× 25 0.2× 22 802
Hua Tang China 12 81 0.5× 154 1.0× 44 0.3× 66 0.5× 36 0.3× 25 451
Luis A. Costa Spain 11 281 1.7× 185 1.2× 43 0.3× 234 1.9× 19 0.2× 21 659
D. Dean United Kingdom 17 96 0.6× 72 0.5× 186 1.3× 192 1.5× 226 2.1× 31 659
Hee Soon Cho South Korea 9 77 0.5× 43 0.3× 93 0.6× 63 0.5× 125 1.1× 23 313

Countries citing papers authored by David O’Brien

Since Specialization
Citations

This map shows the geographic impact of David O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O’Brien more than expected).

Fields of papers citing papers by David O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O’Brien. The network helps show where David O’Brien may publish in the future.

Co-authorship network of co-authors of David O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of David O’Brien. A scholar is included among the top collaborators of David O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David O’Brien. David O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fogarty, Helen, David O’Brien, Christopher L. Bacon, et al.. (2020). Biclonal lymphoproliferative disorders: another association with NOTCH1-mutated chronic lymphocytic leukaemias. Irish Journal of Medical Science (1971 -). 190(3). 1087–1094. 2 indexed citations
3.
Crampe, Mireille, et al.. (2019). Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3BCR-ABL1Fusion. SHILAP Revista de lepidopterología. 2019. 1–4. 2 indexed citations
4.
Langabeer, Stephen E., David O’Brien, Sarah L. McCarron, et al.. (2019). Hairy Cell Leukemia Masquerading as Pancytopenia in Pregnancy. SHILAP Revista de lepidopterología. 2019. 1–3. 2 indexed citations
5.
6.
Browne, Paul, Eibhlin Conneally, Catherine Flynn, et al.. (2015). Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL. Irish Journal of Medical Science (1971 -). 185(4). 773–777. 3 indexed citations
7.
Ryan, Elizabeth, Margaret O’Brien, Seamus Looby, et al.. (2014). Genetic features of oligodendrogliomas and presence of seizures. The relationship of seizures and genetics in LGOs. Clinical Neuropathology. 33(7). 292–298. 14 indexed citations
8.
Francis, Sebastian, Claire Lucas, Steven Lane, et al.. (2013). A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia. Leukemia Research. 37(7). 752–758. 9 indexed citations
9.
O’Brien, David, Peter F. Moore, William Vernau, et al.. (2013). Clinical Characteristics and Outcome in Dogs with Splenic Marginal Zone Lymphoma. Journal of Veterinary Internal Medicine. 27(4). 949–954. 18 indexed citations
10.
Langabeer, Stephen E., et al.. (2012). Incidence of the BRAF V600E mutation in chronic lymphocytic leukaemia and prolymphocytic leukaemia. Leukemia Research. 36(4). 483–484. 23 indexed citations
11.
Langabeer, Stephen E., David O’Brien, Catherine Flynn, et al.. (2012). Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype. International Journal of Laboratory Hematology. 34(4). 417–421. 21 indexed citations
12.
Kelly, Kevin R., David O’Brien, Fiona Quinn, et al.. (2010). Large granular lymphocyte leukemia: natural history and response to treatment. Leukemia & lymphoma. 51(5). 839–845. 25 indexed citations
13.
McGuckin, Siobhan, Eibhlin Conneally, Shaun R. McCann, et al.. (2009). Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia. Irish Journal of Medical Science (1971 -). 178(4). 441–446. 3 indexed citations
14.
O’Brien, David, Barnaby Clark, & K. Dilip. (2007). α78(EF7)Asn→Asp is a Posttranslational Modification in Hb J-Singapore [α78(EF7)Asn→Asp;α79(EF8)Ala→Gly]. Hemoglobin. 31(4). 483–489. 4 indexed citations
15.
O’Brien, David & Cecil H. Rorabeck. (2006). Managing bone loss in revision total hip arthroplasty: the acetabulum.. PubMed. 55. 263–77. 7 indexed citations
16.
O’Brien, David, et al.. (2003). Haemoglobin Etobicoke, an incidental finding in an Irish diabetic. Clinical & Laboratory Haematology. 25(4). 259–262. 4 indexed citations
17.
McMahon, Corrina, et al.. (2001). The increasing prevalence of childhood sickle-cell disease in Ireland. Irish Journal of Medical Science (1971 -). 170(3). 183–185. 5 indexed citations
18.
Hundle, Bhupinder S., et al.. (1993). In vitro expression and activity of lycopene cyclase and β‐carotene hydroxylase from Erwinia herbicola. FEBS Letters. 315(3). 329–334. 48 indexed citations
19.
Ma, D, David N. Cook, David O’Brien, & John E. Hearst. (1993). Analysis of the promoter and regulatory sequences of an oxygen-regulated bch operon in Rhodobacter capsulatus by site-directed mutagenesis. Journal of Bacteriology. 175(7). 2037–2045. 43 indexed citations
20.
Goldberg, Eugene P., et al.. (1988). Prevention of postoperative pericardial adhesions with hydrophilic polymer solutions. Journal of Surgical Research. 45(1). 44–49. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katia Chieregato Breakdown of academic impact, for papers by Laurent Bégot Breakdown of academic impact, for papers by Valentina Devescovi Breakdown of academic impact, for papers by Francisco Carbonell‐Uberos Breakdown of academic impact, for papers by Gang Ding Breakdown of academic impact, for papers by Jianmao Zheng Breakdown of academic impact, for papers by Hua Tang Breakdown of academic impact, for papers by Luis A. Costa Breakdown of academic impact, for papers by D. Dean Breakdown of academic impact, for papers by Hee Soon Cho
Rankless by CCL
2026